BioCentury
ARTICLE | Clinical News

Aptivus tipranavir regulatory update

June 30, 2008 7:00 AM UTC

FDA approved an sNDA for Aptivus tipranavir capsules for use in combination with ritonavir for treatment-experienced pediatric patients aged 2-18 years, which will be available shortly. The capsule fo...